These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7826863)

  • 21. Clerocidin, a terpenoid antibiotic, inhibits bacterial DNA gyrase.
    McCullough JE; Muller MT; Howells AJ; Maxwell A; O'Sullivan J; Summerill RS; Parker WL; Wells JS; Bonner DP; Fernandes PB
    J Antibiot (Tokyo); 1993 Mar; 46(3):526-30. PubMed ID: 8386713
    [No Abstract]   [Full Text] [Related]  

  • 22. Usual and unusual antibacterial effects of quinolones.
    Furet YX; Pechère JC
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():7-15. PubMed ID: 2175306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde.
    Anderson VE; Osheroff N
    Curr Pharm Des; 2001 Mar; 7(5):337-53. PubMed ID: 11254893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action.
    Heddle JG; Barnard FM; Wentzell LM; Maxwell A
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1249-64. PubMed ID: 11097055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA gyrase as a drug target.
    Maxwell A
    Biochem Soc Trans; 1999 Feb; 27(2):48-53. PubMed ID: 10093705
    [No Abstract]   [Full Text] [Related]  

  • 27. Mode of action of the quinolone antimicrobial agents: review of recent information.
    Hooper DC; Wolfson JS
    Rev Infect Dis; 1989; 11 Suppl 5():S902-11. PubMed ID: 2549608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 4-quinolone antibiotics: past, present, and future.
    Stein GE
    Pharmacotherapy; 1988; 8(6):301-14. PubMed ID: 2851772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
    Chen CR; Malik M; Snyder M; Drlica K
    J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.
    Collin F; Karkare S; Maxwell A
    Appl Microbiol Biotechnol; 2011 Nov; 92(3):479-97. PubMed ID: 21904817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ofloxacin, a bactericidal antibacterial.
    Smith JT
    Chemotherapy; 1991; 37 Suppl 1():2-13. PubMed ID: 1646700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
    Strahilevitz J; Robicsek A; Hooper DC
    Antimicrob Agents Chemother; 2006 Feb; 50(2):600-6. PubMed ID: 16436716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Causes of quinolone resistance in gram-negative bacteria].
    Cullmann W
    Immun Infekt; 1990 Jun; 18(3):80-8. PubMed ID: 2165997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mode of action of fluoroquinolones.
    Hooper DC
    Drugs; 1999; 58 Suppl 2():6-10. PubMed ID: 10553698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of plasmid-mediated quinolone resistance.
    Tran JH; Jacoby GA
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5638-42. PubMed ID: 11943863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereo (C7)-dependent topoisomerase II inhibition and tumor growth suppression by a new quinolone, BO-2367.
    Yoshinari T; Mano E; Arakawa H; Kurama M; Iguchi T; Nakagawa S; Tanaka N; Okura A
    Jpn J Cancer Res; 1993 Jul; 84(7):800-6. PubMed ID: 8396568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinolone interactions with DNA and DNA gyrase.
    Shen LL
    Methods Mol Biol; 2001; 95():171-84. PubMed ID: 11089230
    [No Abstract]   [Full Text] [Related]  

  • 38. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
    Domagala JM; Hanna LD; Heifetz CL; Hutt MP; Mich TF; Sanchez JP; Solomon M
    J Med Chem; 1986 Mar; 29(3):394-404. PubMed ID: 3005575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: specificity and cooperativity of drug binding to DNA.
    Shen LL; Baranowski J; Pernet AG
    Biochemistry; 1989 May; 28(9):3879-85. PubMed ID: 2546584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory activity on DNA gyrase and intracellular accumulation of quinolones: structure-activity relationship of Q-35 analogs.
    Ito T; Kojima K; Koizumi K; Nagano H; Nishino T
    Biol Pharm Bull; 1994 Jul; 17(7):927-30. PubMed ID: 8000379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.